GlaxoSmithKline
All perspectives on AI disruption for GlaxoSmithKline
Analyst Perspective
ENTITY: GLAXOSMITHKLINE PLC - AI DRUG DISCOVERY REALITY CHECK
FROM: The 2030 Report | Healthcare, Pharmaceuticals, and Biotech Intelligence Division
CEO Perspective
GLAXOSMITHKLINE: NAVIGATING PATENT CLIFFS AND AI-ENABLED PHARMACEUTICAL INNOVATION
From: The 2030 Report
Employee Perspective
GLAXOSMITHKLINE: ARTIFICIAL INTELLIGENCE AND THE FUTURE OF PHARMACEUTICAL RESEARCH
A Macro Intelligence Memo | June 2030 | Employee Edition